COVID-19, northwestern university and Moderna
Moderna appropriated Northwestern research for COVID vaccine, lawsuit alleges
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own researchers' technological breakthroughs.
Northwestern is suing one of the makers of the COVID-19 vaccines
The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been possible without research done in the Chicago area at Northwestern University.
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax.
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA.
GSK sues Moderna for US patent infringement over COVID, RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.
Northwestern sues Moderna for alleged patent infringement in COVID shots
Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to combat the pandemic.
British drugmaker sues Moderna for patent infringement related to mRNA vaccines
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent rights in its mRNA technology used to develop its COVID-19 and RSV vaccines.
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Medpage Today on MSN2d
Serena Williams' Surgery; Moderna Sued Over COVID Vax; Brighter Nights and Mortality
Retired tennis star Serena Williams said she underwent a procedure to remove a benign branchial cyst "the size of a small ...
XEC variant 'might escape Covid vaccine defences'
The XEC variant of Covid is quickly becoming the dominant strain of the winter, but the current vaccines may not be as ...
AOL2d
Here’s What You Need to Know About Getting the New 2024 COVID Vaccine
There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna, and a ...
The Martha's Vineyard Times1d
COVID, flu vaccine clinic announced
The Vineyard boards of health are teaming up to bring vaccines back to the community at the end of the month. It’s not the ...
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...
A new COVID-19 vaccine has been approved for Australians. Here's what to know
The Therapeutic Goods Administration has given Pfizer's new COVID-19 jab the green light. But what about vaccines from ...